Building a neuroinfectious disease consensus curriculum.

Central Nervous System Infections Clinical Competence Curriculum Delphi Technique Humans Neurology / education

Journal

Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060

Informations de publication

Date de publication:
30 07 2019
Historique:
received: 01 03 2019
accepted: 03 05 2019
pubmed: 30 6 2019
medline: 7 1 2020
entrez: 30 6 2019
Statut: ppublish

Résumé

To delineate a comprehensive curriculum for fellowship training in neuroinfectious diseases, we conducted a modified Delphi approach to reach consensus among 11 experts in the field. The authors invited a diverse range of experts from the American Academy of Neurology Neuro-Infectious Diseases (AAN Neuro-ID) Section to participate in a consensus process using a modified Delphi technique. A comprehensive list of topics was generated with 101 initial items. Through 3 rounds of voting and discussion, a curriculum with 83 items reached consensus. The modified Delphi technique provides an efficient and rigorous means to reach consensus on topics requiring expert opinion. The AAN Neuro-ID section provided the pool of diverse experts, the infrastructure, and the community through which to accomplish the consensus project successfully. This process could be applied to other subspecialties and sections at the AAN.

Identifiants

DOI: 10.1212/WNL.0000000000007872 PMID: 31253643 PMC: PMC6693428
pubmed: 31253643
pii: WNL.0000000000007872
doi: 10.1212/WNL.0000000000007872
pmc: PMC6693428
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

208-216

Informations de copyright

© 2019 American Academy of Neurology.

Références

Neurology. 2018 Oct 16;91(16):748-754
pubmed: 30217940
Med Teach. 2005 Nov;27(7):639-43
pubmed: 16332558
Neurology. 2012 Jul 17;79(3):e19-26
pubmed: 22802597
Health Soc Care Community. 1999 May;7(3):198-205
pubmed: 11560634
Neurology. 2015 Jun 2;84(22):2279-83
pubmed: 25934848
Front Neurol. 2017 Sep 14;8:480
pubmed: 28959232
Neurology. 2018 Sep 25;91(13):597-610
pubmed: 30185444
Handb Clin Neurol. 2018;152:265-287
pubmed: 29604981
Can J Neurol Sci. 2017 Mar;44(2):170-176
pubmed: 27846918
PLoS One. 2018 May 17;13(5):e0197463
pubmed: 29771997
Neurology. 2008 Oct 7;71(15):1160-6
pubmed: 18838663
J Adv Nurs. 2003 Feb;41(4):376-82
pubmed: 12581103
Int J Nurs Stud. 2001 Apr;38(2):195-200
pubmed: 11223060
Neurology. 2009 Jul 28;73(4):e14-5
pubmed: 19636042
Neurology. 2009 Jun 9;72(23):2020-3
pubmed: 19506224
Am J Med. 2018 Jan;131(1):25-32
pubmed: 28889928
J Adv Nurs. 2000 Oct;32(4):1008-15
pubmed: 11095242

Auteurs

Arun Venkatesan (A)

From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.

Felicia C Chow (FC)

From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.

Allen Aksamit (A)

From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.

Russell Bartt (R)

From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.

Thomas P Bleck (TP)

From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.

Cheryl Jay (C)

From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.

Daniel M Pastula (DM)

From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.

Karen L Roos (KL)

From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.

Jeffrey Rumbaugh (J)

From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.

Deanna Saylor (D)

From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City.

Tracey A Cho (TA)

From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City. tracey-cho@uiowa.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies du système nerveux › Maladies du système nerveux central › Infections du système nerveux central › Building a neuroinfectious disease consensus...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Compétence clinique › Building a neuroinfectious disease consensus...
questionsmedicales.fr › Éducation › Programme d'études › Building a neuroinfectious disease consensus...
questionsmedicales.fr › Sciences de l'information › Analyse des systèmes › Méthode Delphi › Building a neuroinfectious disease consensus...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Building a neuroinfectious disease consensus...
questionsmedicales.fr › Professions de santé › Médecine › Neurologie › Building a neuroinfectious disease consensus...